Germline mutations in the LKB1 gene are responsible for Peutz-Jeghers syndrome (PJS), which is characterized by gastrointestinal hamartomas and increasing risk of cancer. Mice with Lkb1 þ /À mutation develop gastric hamartomas after >20 weeks of age, and hepatocellular adenomas and carcinomas >30 weeks. It has been reported that, in PJS patients, carcinomas progressed from hamartomas contain p53 mutations, and that LKB1 regulates p53-dependent apoptosis. To investigate the roles of LKB1 and p53 mutations in tumorigenesis, we constructed compound mutant mice of Lkb1 and p53 genes. In the Lkb1
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À/À mice, formation of gastric hamartomas and hepatic tumors was accelerated. However, histopathology of hamartomas was similar between Lkb1
À/À and Lkb1 þ /À mice, and Lkb1 genotype remained heterozygous, suggesting that the p53 mutation affected hamartoma initiation. Contrary to the heterozygous hamartomas in the stomach and duodenum, the hepatic adenomas in Lkb1 þ /À p53 À/À mice showed loss of Lkb1 heterozygosity (LOH), suggesting that lack of p53 stimulated Lkb1 LOH and tumor initiation in the liver. Taken together, these results indicate that lack of p53 causes earlier onsets of gastric hamartomas and hepatic tumors in Lkb1
À/À mice. Oncogene (2006 Oncogene ( ) 25, 1816 Oncogene ( -1820 Oncogene ( . doi:10.1038 published online 7 November 2005 Keywords: LKB1; p53; Peutz-Jeghers syndrome; hamartoma; HCC Peutz-Jeghers syndrome (PJS) is an autosomal dominant disease characterized by gastrointestinal polyps, mucocutaneous pigmentation and increasing risk of cancer (Giardiello et al., 1987; Spigelman et al., 1989) . The LKB1 gene encodes a serine/threonin kinase (Hemminki et al., 1998; Jenne et al., 1998) that is involved in cell cycle control (Tiainen et al., 1999) , energy metabolism (Hawley et al., 2003; Woods et al., 2003) , p53-dependent apoptosis (Karuman et al., 2001) and cell polarity (Baas et al., 2004) . The p53 tumor suppressor gene encodes a transcription factor that controls DNA damage-induced cell cycle arrest and apoptosis. More than 50% of human cancers contain mutations in p53 (Levine, 1997) . Notably, the gastrointestinal adenocarcinomas in PJS patients contain p53 mutations (Gruber et al., 1998; Miyaki et al., 2000; Takahashi et al., 2004) . These pieces of evidence suggest functional cooperation between LKB1 and p53 in tumor suppression.
We have reported recently that Lkb1 þ /À mice develop gastric hamartomas because of Lkb1 gene haploinsufficiency, that is, without loss of Lkb1 heterozygosity (LOH) . In contrast, hepatocellular carcinoma (HCC) in Lkb1 þ /À mice is caused by Lkb1 LOH . On the other hand, p53 null mutant (p53 À/À ) mice develop lymphomas and sarcomas after B10 weeks of age, without any gastroduodenal hamartomas or hepatic tumors (Donehower, 1996) . To investigate possible interaction of LKB1 and p53 mutations in tumorigenesis, we generated Lkb1
À/À compound mutant mice. First, we compared the onset of the gastric hamartoma. Since gastric hamartomas in Lkb1 þ /À mice arose after >20 weeks of age Figure 1a and c). At 24 weeks of age, all (4/4) Lkb1
þ /À mice developed hamartomas showing that the onset of hamartomas was slightly earlier than in Lkb1 þ /À mice (Table 1) . These results indicate that lack of p53 causes earlier onset of gastric hamartomas in Lkb1 þ /À mice, in a manner dependent on the mutated p53 gene dosage.
To determine whether lack of p53 caused any histopathological changes, we next examined the gastric hamartomas in Lkb1 þ /À and Lkb1
À/À mice, hamartomas were composed of glandular and cystic epithelial layers, without any dysplastic signs (Figure 1e and f). Since an arborizing network of the smooth muscle is one of the typical features of the hamartomas in PJS and Lkb1 þ /À mice Bronner, 2003) , we performed immunohistochemistry for a smooth muscle actin (aSMA) in polyps of Lkb1 þ /À and Lkb1
mice. We found similar patterns of network composed of the smooth muscle bundles in the polyps of both genotypes (Figure 1g and h). These results indicate that lack of p53 does not affect histopathological features of Lkb1 þ /À mouse gastric hamartomas. The Lkb1 gene of the gastric hamartoma tissue in Lkb1 þ /À mice remains haploid, that is, haploinsufficiency . To determine whether additional p53 À/À mutation affected the Lkb1 genotype in the hamartoma, we isolated genomic DNA from the hamartomatous epithelium of Lkb1
À/À mice by laser microdissection, and analysed the Lkb1 genotype by genomic DNA PCR. We found that the wild-type allele remained in the polyp tissue of the Lkb1 
ND, not determined. a C57BL/6 NTac-Trp53 tm1 N12 knockout mice were purchased from Taconic M&B. The Lkb1 +/À mice were constructed as described previously . Stomachs were fixed with 4% paraformaldehyde overnight. Specimens were dehydrated, embedded with paraffin, and 4-mm thick sections were stained with H&E. Histopathology shows that hamartomas of both Lkb1 þ /À (e) and Lkb1 þ /À p53 À/À (f) mice are composed of glandular and cystic epithelial layers (e, f, insets). Immunohistochemistry of aSMA in hamartomas of Lkb1 þ /À (g) and Lkb1
þ /À p53 À/À (h) mice, according to the method as described . Bars, 5 mm (a-d), 50 mm (e-h). Genomic PCR of wild-type (WT) and targeted (KO) alleles of Lkb1 in gastric epithelia of Lkb1 þ /À p53 À/À mice (i). The MEFs of Lkb1 þ /À and Lkb1 À/À were used as controls. N, normal gastric epithelium; P, hamartomatous polyp epithelium. For DNA extraction from the paraffin-embedded Lkb1 þ /À p53 À/À mouse stomach, sections (8 mm) were stained with hematoxylin, and dissected using a laser microdissection system (Leica, Germany). Dissected samples were lysed in 20 ml of lysis buffer (10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 1% Tween 20, 50 mg/ml Protease K) overnight at 551C. After inactivation of protease at 951C for 10 min, 1 ml of aliquots were used in 10 ml-mixtures for PCR. For LOH analysis, two primer sets were used to detect the targeted and wild-type Lkb1 alleles (I1F; GTGCATGTCTGGGAGCTCTT, and neoF; GGGAGGATTGG-GAAGACAAT) and (I1F, and E2R; CTGAAGGTCAGCCCT-GAGAC). The PCR condition for both primer pairs was one cycle for 3 min at 941C; 30 cycles for 30 s at 941C, 30 s at 631C and 30 s at 721C; followed by one cycle for 5 min at 721C. The PCR products were analysed in 2% agarose gels, stained with SYBR Green I (Cambrex) and visualized with a fluorescence imager, LAS-1000 Plus (Fuji, Japan). We generated MEFs from 9.5 dpc embryos and cultured them in DMEM (Sigma) containing 10% FBS (Biowest). Expression of Lkb1 in the normal gastric epithelium and hamartomas of Lkb1 þ /À and Lkb1 þ /À p53 À/À mice (j). Western blotting was performed as described previously . Antibodies used were for Lkb1 (ImmuQuest Ltd, UK) and b-actin (Sigma). N, normal gastric epithelium; P, hamartomatous polyp.
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þ /À p53 À/À mice H Takeda et al mouse (Figure 1i ). In addition, Western blotting analysis showed that the Lkb1 protein level was similar between the normal gastric epithelium and hamartomas in Lkb1
À/À mice (Figure 1j ). These results suggest that Lkb1
À/À mice develop hamartomas without Lkb1 LOH. As the Lkb1 protein level was similar also between Lkb1 þ /À and Lkb1 þ /À p53 À/À hamartomas, lack of p53 did not appear to affect Lkb1 expression (Figure 1j ). To investigate whether lack of p53 affected cell survival, we next analysed growth and apoptosis in the hamartoma epithelium. The immunostaining for Ki-67 (DakoCytomation) showed that proliferation index was not significantly different between hamartomas of Lkb1 þ /À and Lkb1
À/À mice (data not shown). Although it was reported that LKB1 regulated p53-dependent apoptosis (Karuman et al., 2001) , the fraction of TUNEL-positive cells in hamartoma epithelium was not different between Lkb1 þ /À and 
À/À mice (0.19 and 0.20%, respectively). These results suggest that lack of p53 does not affect growth or apoptosis in the hamartoma.
Regarding the effect of p53 mutations on gastric tumorigenesis, Cdx2-transgenic mice develop gastric polyps after >80 weeks of age, whereas introduction of p53 þ /À mutation to these mice causes earlier onset of the gastric polyps (Mutoh et al., 2004) . To investigate whether Cdx2 was involved in the earlier onset of hamartomas in Lkb1
À/À mice, we performed immunohistochemistry for Cdx2 (Seno et al., 2002) . However, we found no expression of Cdx2 in hamartomas of Lkb1
À/À mice (data not shown), suggesting that Cdx2 was hardly involved. Although p53 mutations have been reported in the carcinomatous lesions in PJS patients (Gruber et al., 1998; Miyaki et al., 2000; Takahashi et al., 2004) , the hamartomas of the Lkb1 þ /À p53 À/À mice remained benign. As Lkb1
mice die young (B7 months of age), it may be too early to accumulate further genetic alterations in the stomach. It is also conceivable that, in humans, environmental factors such as infection and inflammation stimulate additional genetic changes (Crowe, 2005) , whereas we have analysed mice kept in a specific pathogen-free facility. Taken together, lack of p53 appears to accelerate hamartoma initiation through a mechanism that is independent of apoptosis. We reported recently that Lkb1 þ /À mice developed not only gastric hamartomas but also hepatic nodular foci (NdFc) and HCC. Namely, NdFc formed after 30 weeks of age, and HCC after 40 weeks . Therefore, we next investigated whether lack of p53 affected tumorigenesis in the liver. In Lkb1 þ /À p53 À/À mice, we found NdFc (Figure 2a ) in 12 mice and HCC ( Figure 2c ) in a mouse between 25 and 30 weeks of age. These results suggest that the onsets of the hepatic lesions are also accelerated in Lkb1 Table 2 ). The NdFc of Lkb1 þ /À p53 À/À mice consisted of large dysplastic hepatocytes with normal nuclear/ cytoplasmic ratio (Figure 2b) , showing the same histopathology as those in Lkb1 þ /À mice . Likewise, histopathology of HCC (Figure 2d ) in the Lkb1
À/À mouse was similar to that in Lkb1
mice . As NdFc or HCC was not reported in p53 À/À mice (Donehower, 1996) , it appeared that the Lkb1 mutation was responsible for the liver tumors in Lkb1
mice. Therefore, we next investigated whether Lkb1 LOH took place in the hepatic lesions of Lkb1 þ /À p53 À/À mice. In both HCC and NdFc, we found significantly decreased band intensities for the wild-type allele, compared with those for the normal tissue (Figure 2g) , showing the association of Lkb1 LOH with the hepatic lesions in Lkb1 þ /À p53 À/À mice. Although we detected a faint band for the wild-type allele in the hepatic lesions, it was likely derived from infiltrated lymphocytes, because lymphomas were often found in the liver of most Lkb1
À/À mice older than 10 weeks. Regarding the functions of p53 in tumorigenesis, the Rb
À/À mice show enhanced tumorigenesis compared with Rb þ /À mice, and the tumors from Rb
mice often show Rb LOH (Williams et al., 1994) , which is likely due to increased chromosomal instability by loss of p53 (Livingstone et al., 1992) . Therefore, also in Lkb1
À/À mice, lack of p53 accelerates the onsets of the hepatic lesions most likely by promoting Lkb1 LOH.
In addition to the hepatic lesions in the Lkb1
mice, we found a bladder tumor in a 25-week old and ovarian cancers in two mice of B30-week old (Table 1) , although Lkb1 þ /À or p53 À/À mice did not develop such tumors. A cell line established from the ovarian cancer was transplantable in nude mice, and the tumor was of the stromal cell type, histopathologically (Figure 2e ). Since these ovarian cancers showed Lkb1 LOH (Figure 2g) , total loss of LKB1 may cause malignant tumors in the ovary. Notably, ovarian cancer, especially of the stromal cell type, is often found in PJS patients (Papageorgiou and Stratakis, 2002) , and the Lkb1
À/À mouse can be a useful model. On the other hand, the bladder cancer was classified as a transitional cell papilloma (Figure 2f ). Since the bladder cancer did not show Lkb1 LOH (Figure 2g ), Lkb1 haploinsufficiency and lack of p53 may be responsible for the benign tumor. Although bladder cancer has not been reported in PJS patients, it remains to be determined whether a subset of sporadic bladder cancer contains LKB1 mutations.
In conclusion, we have generated and analysed compound mutant mice for Lkb1 and p53 genes. Additional mutation in the p53 gene in Lkb1 mutant mice accelerates tumorigenesis in the stomach and liver. In addition, LKB1 may play additional roles as a tumor suppressor gene in several other organs, including the ovary and bladder. (Donehower, 1996) . The frequencies of these neoplasms were similar between Lkb1 +/À p53 À/À and p53 À/À mice (data not shown). a M, male; F, female.
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